CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-08 | Humphries William D. President, Ortho-Dermatologics | Sale | −5,667 | $16.17 | $92K | 235,035 |
| 2020-08-28 | Spurr Robert President, Salix | Shares withheld for taxes | −1,278 | $17.00 | $22K | 38,972 |
| 2020-08-28 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award | +28,171 | 124,196 | ||
| 2020-08-17 | Humphries William D. President, Ortho-Dermatologics | Shares withheld for taxes | −4,567 | $17.48 | $80K | 240,702 |
| 2020-06-30 | WECHSLER AMY B Director | Grant or award | +375 | $18.29 | $7K | 100,729 |
| 2020-06-30 | ROBERTSON RUSSEL C Director | Grant or award | +2,050 | $18.29 | $37K | 109,489 |
| 2020-06-30 | Paulson John Director | Grant or award | +1,545 | $18.29 | $28K | 70,068 |
| 2020-06-30 | DE SCHUTTER RICHARD U Director | Grant or award | +1,750 | $18.29 | $32K | 293,429 |
| 2020-06-05 | ValueAct Holdings, L.P. Director | Sale | −948,353 | $19.24 | $18.2M | 0 |
| 2020-06-05 | ValueAct Holdings, L.P. Director | Purchase | +948,353 | $19.24 | $18.2M | 17,931,594 |
| 2020-05-14 | Paulson John Director | Purchase | +348,920 | $15.85 | $5.5M | 24,559,035 |
| 2020-05-14 | Paulson John Director | Purchase | +70,000 | $15.65 | $1.1M | 24,629,035 |
| 2020-05-14 | Paulson John Director | Purchase | +624,900 | $15.87 | $9.9M | 25,253,935 |
| 2020-05-14 | Paulson John Director | Purchase | +585,100 | $15.92 | $9.3M | 25,839,035 |
| 2020-05-13 | Paulson John Director | Purchase | +603,900 | $16.32 | $9.9M | 23,483,971 |
| 2020-05-13 | Paulson John Director | Purchase | +80,300 | $16.58 | $1.3M | 23,564,271 |
| 2020-05-13 | Paulson John Director | Purchase | +645,844 | $16.70 | $10.8M | 24,210,115 |
| 2020-05-12 | Paulson John Director | Purchase | +25,000 | $17.30 | $433K | 20,864,035 |
| 2020-05-12 | Paulson John Director | Purchase | +162,900 | $17.50 | $2.9M | 21,026,935 |
| 2020-05-12 | Paulson John Director | Purchase | +374,836 | $17.33 | $6.5M | 21,401,771 |
Page 25 of 31 · 608 trades